We are a regional biopharmaceutical
enterprise that stands at the forefront of
scientific innovation. We are dedicated to
harnessing cutting-edge technologies in the fields of immunology and regenerative
medicine to reshape the future of healthcare.
At All Life, we are pioneers in cellular
engineering. Our ground-breaking
achievements in
• Induced Pluripotent Stem Cells (iPSC) reprogramming and
• Chimeric Antigen Receptor (CAR)
technologies and advancements are not only transforming the medical landscape but also creating healthcare solutions that benefit both the medical and general communities.
ALL LIFE MEDICALS
SCIENCE & TECHNOLOGY
CO. LTD
ALL LIFE Advanced
IMMUNOLOGY
SDN. BHD.
ALL LIFE
BIO TECHNOLOGY
SDN. BHD.
CORE RESEARCHERS
Supported by 120+
In-house Scientists
• RESEARCH
• CLINICAL
• APPLICATIONS DEVELOPMENT
• COMMERCIALIZATION
CORE RESEARCHERS
clinical trials
OVARIAN CANCER
COLORECTAL CANCER
PROSTATE CANCER
LEUKEMIA
B CELL LYMPHOMA
MULTIPLE MELOMA
LOU GEHRIG’S DISEASE (ALS)
PARKINSON
BRAIN & SPINAL CORD INJURY
ISCHEMIC STROKE
TYPE 1 - DIABETES
CAR-NK Research & Clinical Trials
CAR-NK Patent (China) NO.: 20190209997.5
LUNG
COLORECTAL
OVARIAN
LEUKEMIA
BREAST
PROSTATE
LIVER
PANCREATIC
Research and Clinical Trial Status
Cell
Source
Medical
Conditions
R & D /
Preclinical
Phase I /
RF 1
Phase II
Phase III
Anti-CD19 CAR-NK
Leukemia
Anti-CD22 CAR-NK
Leukemia
Anti-CD19/
CD22 CAR-NK
Leukemia
Anti-MSLN CAR-NK
Ovarian Cancer
Anti-PSMA CAR-NK
Prostate Cancer
CD19 iCAR-NK
Leukemia
CAR-NK TECHNOLOGY
Immunotherapy pipeline
Product
Indications
Research
Preclinical
I/II Clinical
ALLLIFE CAR-NK CD19
Acute B Leukemia (ALL)
ALLLIFE CAR-NK BCMA
Multiple Myeloma (MM)
ALLLIFE CAR-NK PMSA
Prostatic Cancer
ALLLIFE CAR-NK Meso
Ovarian Cancer
Induced Pluripotant Stem Cell (iPSC) Research &
Clinical Trials
Research and Clinical Trial Status
Cell
Source
Medical
Conditions
R & D /
Preclinical
Phase I /
RF 1
Phase II
Phase III
iISLET
Diabetes Type 1
iWPC
Ischemic Stroke
iNSC
Ischemic Stroke7
iNSC
Parkinson’s
iNSC
Thalassemia
iRPE
Age-related macular degeneration (AMD)
IPSC REPROGRAMMING
Induced Pluripotent Stem Cells (iPSC) derived pipeline
Product
Applications
Research
Preclinical
I/II Clinical
Hematopoietic Stem Cells (iHSC)
Fabry/Thalassemia
Neuron Stem Cells (iNSC)
ALS
Islet Cells (iISLET)
Diabetes/Demyelination
Endothelial Progenitor Cells (iEPC)
Heart Failures
Hematopoietic Stem Cells (iHSC)
Transplantation/Blood Cancers
Neuron Stem Cells (iNSC)
Parkinson’s/Ischemic Stroke
PRODUCTS
PRODUCTS
(Autologous): NK+
1.0 billion cells: Medical & General Wellness
4.0 billion cells: Medical & General Wellness
10.0 billion cells: Medical
1.0 billion cells: Medical & General Wellness
4.0 billion cells: Medical & General Wellness
10.0 billion cells: Medical
1.0 billion cells: Medical
4.0 billion cells: Medical
10.0 billion cells: Medical
PRODUCTS
SERVICES
Original Bio-Manufacturer
We rely on the latest high-tech manufacturing equipment and dedicated professional staff who are operational in both R&D and manufacturing. We provide a full range of product development services, from production of raw materials for formulation to packaging and design as well as consultation services.
Customized Therapy
The challenge we face today is the threat to our quality-of-life brought on by diseases, which are caused by ‘diseased’ cells, whereby current available treatment options are merely treating or managing the symptoms of these diseases. We are at the forefront in cellular reprogramming and NK-based engineering technologies. Depending on the age of the patient, type of disease, malignancy, stage, and status of the disease, we work with highly-skilled and trained medical professionals to develop and design innovative, accessible solutions using our technological assets to deliver customized therapies for each unique individual.
Customized Product Formulation
Custom formulation is the creation of a product made exclusively for you or your company based on your specifications. If you are looking for an exclusive formula for your product and do not have an in-house product development team, look no further, we at ALL LIFE can assist.
Our state-of-the art GMP certified laboratory and highly experienced team of scientists utilize advanced technologies and delivery systems to formulate an exclusive product just for you. If you have a concept in mind for a customized product our knowledgeable R&D team can assist in creating a unique formulation tailored exactly to your specifications, resulting in a profitable product suited to appeal to your target demographic.
All life talk series
Video board
CONTACT US
info@alllifegroup.com
Customer service: +(603) 7863 9888
Copyright © 2022 ALL LIFE ADVANCED IMMUNOLOGY SDN BHD 201701021857 (1236023-V). All Rights Reserved
TERMS OF USE | PRIVACY POLICY
We are a regional biopharmaceutical
enterprise that stands at the forefront of
scientific innovation. We are dedicated to
harnessing cutting-edge technologies in the fields of immunology and regenerative
medicine to reshape the future of healthcare.
At All Life, we are pioneers in cellular
engineering. Our ground-breaking
achievements in
• Induced Pluripotent Stem Cells (iPSC) reprogramming and
• Chimeric Antigen Receptor (CAR)
technologies and advancements are not only transforming the medical landscape but also creating healthcare solutions that benefit both the medical and general communities.
ALL LIFE MEDICALS SCIENCE & TECHNOLOGY CO. LTD
ALL LIFE Advanced
IMMUNOLOGY
SDN. BHD.
ALL LIFE
BIO TECHNOLOGY
SDN. BHD.
CORE
RESEARCHERS
Supported by 120+
In-house Scientists
• RESEARCH
• CLINICAL
• APPLICATIONS DEVELOPMENT
• COMMERCIALIZATION
CORE RESEARCHERS
CLINICAL
TRIALS
OVARIAN CANCER
COLORECTAL CANCER
PROSTATE CANCER
LEUKEMIA
B CELL LYMPHOMA
MULTIPLE MELOMA
LOU GEHRIG’S DISEASE (ALS)
PARKINSON
BRAIN & SPINAL CORD INJURY
ISCHEMIC STROKE
TYPE 1 - DIABETES
CAR-NK Research & Clinical Trials
CAR-NK Patent (China) NO.: 20190209997.5
LUNG
COLORECTAL
OVARIAN
LEUKEMIA
BREAST
PROSTATE
LIVER
PANCREATIC
Research and Clinical Trial Status
Cell Source : Anti-CD19 CAR-NK
Medical Conditions: Leukemia
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
Cell Source : Anti-CD22 CAR-NK
Medical Conditions: Leukemia
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
Cell Source : Anti-CD19/CD22 CAR-NK
Medical Conditions: Leukemia
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
Cell Source : Anti-MSLN CAR-NK
Medical Conditions: Ovarian Cancer
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
Cell Source : Anti-PSMA CAR-NK
Medical Conditions: Prostate Cancer
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
Cell Source : CD19 iCAR-NK
Medical Conditions: Leukemia
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
CAR-NK TECHNOLOGY
Induced Pluripotant Stem Cell (iPSC) Research &
Clinical Trials
Research and Clinical Trial Status
Cell Source : iISLET
Medical Conditions: Diabetes Type 1
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
Cell Source : iWPC
Medical Conditions: Ischemic Stroke
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
Cell Source : iNSC
Medical Conditions: Ischemic Stroke7
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
Cell Source : iNSC
Medical Conditions: Parkinson’s
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
Cell Source : iNSC
Medical Conditions: Thalassemia
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
Cell Source : iRPE
Medical Conditions: Age-related macular degeneration (AMD)
R & D /Preclinical
Phase I /RF 1
Phase II
Phase III
IPSC REPROGRAMMING
Immunotherapy pipeline
Product: ALLLIFE CAR-NK CD19
Indications: Acute B Leukemia (ALL)
Research
Preclinical
I/II Clinical
Product: ALLLIFE CAR-NK BCMA
Indications: Multiple Myeloma (MM)
Research
Preclinical
I/II Clinical
Product: ALLLIFE CAR-NK PMSA
Indications: Prostatic Cancer
Research
Preclinical
I/II Clinical
Product: ALLLIFE CAR-NK Meso
Indications: Ovarian Cancer
Research
Preclinical
I/II Clinical
Induced Pluripotent Stem Cells (iPSC) derived pipeline
Product: Hematopoietic Stem Cells (iHSC)
Applications: Fabry/Thalassemia
Research
Preclinical
I/II Clinical
Product: Neuron Stem Cells (iNSC)
Applications: ALS
Research
Preclinical
I/II Clinical
Product: Islet Cells (iISLET)
Applications: Diabetes/Demyelination
Research
Preclinical
I/II Clinical
Product: Endothelial Progenitor Cells (iEPC)
Applications: Heart Failures
Research
Preclinical
I/II Clinical
Product: Hematopoietic Stem Cells (iHSC)
Applications: Transplantation/Blood Cancers
Research
Preclinical
I/II Clinical
Product: Neuron Stem Cells (iNSC)
Applications: Parkinson’s/Ischemic Stroke
Research
Preclinical
I/II Clinical
PRODUCTS
PRODUCTS
PRODUCTS
(Autologous): NK+
1.0 billion cells: Medical & General Wellness
4.0 billion cells: Medical & General Wellness
10.0 billion cells: Medical
1.0 billion cells: Medical & General Wellness
4.0 billion cells: Medical & General Wellness
10.0 billion cells: Medical
1.0 billion cells: Medical
4.0 billion cells: Medical
10.0 billion cells: Medical
SERVICES
Original Bio-Manufacturer
We rely on the latest high-tech manufacturing equipment and dedicated professional staff who are operational in both R&D and manufacturing. We provide a full range of product development services, from production of raw materials for formulation to packaging and design as well as consultation services.
Customized Therapy
The challenge we face today is the threat to our quality-of-life brought on by diseases, which are caused by ‘diseased’ cells, whereby current available treatment options are merely treating or managing the symptoms of these diseases. We are at the forefront in cellular reprogramming and NK-based engineering technologies. Depending on the age of the patient, type of disease, malignancy, stage, and status of the disease, we work with highly-skilled and trained medical professionals to develop and design innovative, accessible solutions using our technological assets to deliver customized therapies for each unique individual.
Customized Product Formulation
Custom formulation is the creation of a product made exclusively for you or your company based on your specifications. If you are looking for an exclusive formula for your product and do not have an in-house product development team, look no further, we at ALL LIFE can assist.
Our state-of-the art GMP certified laboratory and highly experienced team of scientists utilize advanced technologies and delivery systems to formulate an exclusive product just for you. If you have a concept in mind for a customized product our knowledgeable R&D team can assist in creating a unique formulation tailored exactly to your specifications, resulting in a profitable product suited to appeal to your target demographic.
All life talk series
Video board
CONTACT US
info@alllifegroup.com
Customer service:
+(603) 7863 9888
Copyright © 2022 ALL LIFE ADVANCED IMMUNOLOGY SDN BHD 201701021857 (1236023-V). All Rights Reserved
TERMS OF USE | PRIVACY POLICY